Evidence map›Paper›PMID 35728424›Full record

ArticleJournal of infection and public health2022

SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.

Fadi AlJamaan, Mohamad-Hani Temsah, Khalid Alhasan, Shuliweeh Alenezi, Ali Alhaboob, Abdulkarim Alrabiaah, Mohammed Batais, Fatimah Alshahrani, Rasha Asaad Assiri, Hind Bafaqih and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of infection and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 6 countries.

Fadi AlJamaanCritical Care Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: faljamaan@ksu.edu.sa.
Mohamad-Hani TemsahPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Prince Abdullah Ben Khaled Celiac Disease Research Chair, Department of Pediatrics, Faculty of Medicine, King Saud University, Saudi Arabia. Electronic address: mtemsah@ksu.edu.sa.
Khalid AlhasanPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Pediatric Kidney Transplant, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: kalhasan@ksu.edu.sa.
Shuliweeh AleneziDepartment of Psychiatry, King Saud University, Riyadh, Saudi Arabia. Electronic address: salenizi@ksu.edu.sa.
Ali AlhaboobPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: drhbooob@gmail.com.
Abdulkarim AlrabiaahPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: alrabiaah@ksu.edu.sa.
Mohammed BataisDepartment of Family and Community Medicine, King Saud University Medical City, Riyadh, Saudi Arabia. Electronic address: mbatais@ksu.edu.sa.
Fatimah AlshahraniDivision of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University and King Saud University Medical City, Riyadh, Saudi Arabia. Electronic address: Falshahrani1@ksu.edu.sa.
Rasha Asaad AssiriDepartment of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Electronic address: raassiri@pnu.edu.sa.
Hind BafaqihPediatric Critical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: hbafagih13@gmail.com.
Ali AlarajDepartment of Medicine, College of Medicine, Qassim University, Qassim, Saudi Arabia; Dr Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia. Electronic address: al_araj@hotmail.com.
Bedoor Al QadrahPediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: Bedoor29@gmail.com.
Abdulilah AlhaidaryNursing Department, King Saud University Medical City, Riyadh, Saudi Arabia. Electronic address: aalhaidary1@ksu.edu.sa.
Khaled SaadDepartment of Pediatrics, Assiut University, 71516, Egypt. Electronic address: khaled.ali@med.au.edu.eg.
Basema SaddikDepartment of Family and Community Medicine, College of Medicine, University of Sharjah, Sharjah 27272, the United Arab Emirates; Sharjah Institute of Medical Research, University of Sharjah, Sharjah 27272, the United Arab Emirates. Electronic address: bsaddik@sharjah.ac.ae.
Rabih HalwaniSharjah Institute of Medical Research, University of Sharjah, Sharjah 27272, the United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, the United Arab Emirates. Electronic address: rhalwani@sharjah.ac.ae.
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia; Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan. Electronic address: arabaan@gmail.com.
Sarah Al-SubaieCritical Care Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: salsubaie@ksu.edu.sa.
Mazin BarryDivision of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University and King Saud University Medical City, Riyadh, Saudi Arabia; Division of Infectious Diseases, Faculty of Medicine, University of Ottawa, K1H 8M5, Canada. Electronic address: mbarry@ksu.edu.sa.
Jaffar A Al-TawfiqSpecialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaltawfi@yahoo.com.
King Saud University · SAKing Saud Medical City · SAUniversity of Sharjah · AEAssiut University · EGPrincess Nourah bint Abdulrahman University · SARiyadh Armed Forces Hospital · SASaudi Aramco Medical Services Organization · SASulaiman Al Rajhi Colleges · SAUniversity of Haripur · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHerd immunity for COVID-19 is the ultimate goal to end the pandemic. Emergence of SARS-CoV-2 variants has been a subject of considerable debate regarding vaccines effectiveness. This ongoing discussion and other evolving variables contribute to the hesitancy toward vaccines and levels of vaccination acceptance among both the healthcare workers and the public. This study was conducted to assess COVID-19 vaccine uptake and hesitancy among the Saudi Arabian population during the emergence of SARS-CoV-2 Delta variant.

methodsA national cross-sectional survey conducted between June 28 and July 5, 2021. The survey collected sociodemographic information, personal and family history of previous COVID-19 infection, adherence to precautionary measures, COVID-19 vaccination status, parental willingness to vaccinate their teenage children, and address variable associated with hesitancy to receive vaccination.

resultsAmong the 4071 participants, 67 % were women, 86 % of the participants received COVID-19 vaccine, 70 % had very high or high commitment with COVID-19 precautionary measures. On multivariate analysis, vaccine hesitancy was less likely in men (OR 0.652, p-value < 0.001), those who had direct family members infected with COVID-19 (OR 0.455, p-value < 0.001), and those who reported using the Ministry of Health official channels as information sources (OR 0.522, p-value < 0.001), while those younger than 44 years had higher hesitancy to receive the vaccine (1.5-2.1 times). Of the participants, only 42 % showed willingness to vaccinate their teenage (12-18 years old) children.

conclusionsThe participants in this study had high COVID-19 vaccination rate; however, hesitancy was reported more commonly among women. Their willingness to vaccinate their teenage children was much lower. Participants relying on social media platforms were highly hesitant to receive vaccination. Public health officials should scale up their efforts targeting females, young population, and parents by vaccination awareness campaigns, and refute misinformation spread on social media, especially with the emergence of variants and the news burst that coincide with them.

Indexed as

COVID-19VaccinesAdolescentChildCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMalePandemicsSARS-CoV-2Saudi ArabiaVaccinationVaccination HesitancyCOVID-19 VaccinesVaccinesCOVID-19 vaccine hesitancyCOVID-19 vaccine uptakeSARS-CoV-2 Delta variantSaudi Arabia national survey

Identifiers

PMID35728424
PMCPMC9212873
OpenAlexW4283031931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.